First-Line Maintenance with Olaparib and Bevacizumab for Ovarian Cancer
Received Date: Mar 16, 2022 / Published Date: Apr 13, 2022
Citation: Bachvarov D (2022) First-Line Maintenance with Olaparib and Bevacizumab for Ovarian Cancer. Current Trends Gynecol Oncol, 7: 113. Doi: 10.4172/ctgo.1000113
Copyright: © 2022 Bachvarov D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 950
- [From(publication date): 0-2022 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 637
- PDF downloads: 313